Cetyl Myristoleate for Arthritis Science or Speculation - by Rusty Ford

Cetyl Myristoleate for Arthritis
Science for Speculation
By Rusty Ford

There are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across the Internet. Mine is one of them. There have been a number of articles published in little known journals or magazines. There have been four small booklets published. One making fantastic claims, all four filled with anecdotal evidence but offering no real research to back up the claims. There are a number of Doctors sharing the results they are having with their patients but so does every other wonder-working product. The question is, are there any scientific studies to back up any of these claims? The answer is yes. To date there are several patient studies and two double blind studies completed. I will mention the three most prominent below.

Dr Len Sands of the San Diego Clinic completed the first human study on the effectiveness on Cetyl Myristoleate in 1995. There were 48 arthritis patients in this study. All but two showed significant improvement in articular mobility (80% or better) and reduction of pain (70% or better). Obviously the study had its flaws. One doctor conducted the study, there was no control group and the number of participants was small. Even so, it suggested to many that maybe there was some hope here and that more scientific studies should follow.

The first double blind study followed two years later. Dr. H. Siemandi conducted a double blind study under the auspices of the Joint European Hospital Studies Program. There were 431 patients in the study, 106 who received cetyl myristoleate, 99 who received cetyl myristoleate, and glucosamine, sea cucumber, and hydrolyzed cartilage and 226 who received a placebo. Clinical assessment included radiological test and other studies. Results were 63% improvement for the cetyl myristoleate group, 87% for the cetyl myristoleate plus glucosamine group and 15% for the placebo group.

In August of 2002, a double blind study was published in the Journal or Rheumatology. The study included sixty-four patients with chronic knee OA. Half of the patients received a cetyl myristoleate complex and half a placebo. Evaluations included physician assessment, knee range of motion with goniometry, and the Lequesne Algofunctional Index (LAI). The conclusion was that the CM group saw significant improvement while the placebo group saw little to none. In fact in their conclusion the state that CM “may be an alternative to the use of nonsteroidal anti-inflammatory drugs for the treatment of OA”.

Advanced Medical Systems & Design, Ltd completed the last study I would like to mention in Oct 2001. It was not a double blind study but the study included 1814 arthritis patients. The results showed that over 87% of the subjects had greater than 50% recovery and over 65% of those showed from 75% - 100% recovery following a sixteen day regimen. I know that this is not the most scientific study but a study this large does suggest that there could be a positive benefit to the use of CM in the treatment of arthritis.

Conclusion: There is mounting evidence that CM can be effective in the treatment of many forms of arthritis. While it is true that the evidence from these three studies can not be considered conclusive, it is a beginning. It should challenge you to think out side the box and consider that just because it did not come from a drug company does not mean that it will not work. With over 10,000 people a year dying from Nsaids would it not be great to find a safer and more effective product. Especially with the cost of prescription treatments for arthritis costing into the hundreds and good Cetyl Myristoleate products can be found for between $20 and $40.

Rusty Ford
http://arthritis-symptom.com

About the Author

Editor Arthritis-Symptom.com. Author of numerous articles on arthrits and natural health.

More Articles:

  • Arthritis Drugs Celebrex-Vioxx Safety in Doubt - “Arthritis drugs Vioxx, Celebrex safety in doubt”In doubt and may not be as safe as previously thought. Research earlier this year has shown that these drugs increased the risk of heart attacks although a relatively low risk, over those taking a pain reliever. The FDA is debating whether to add information about the increased risk on both drugs’ labels. One Wall Street analyst has warned that this problem could have an adverse effect on Merck, the drug company responsible for these drugs be placed on the market - along with Pharmacia, which makes Celebrex, generating $2.3 billion in 12 months to March

  • Arthritis Pain Relief : Questions To Ask Your Healthcare Provider - Copyright © 2005 Priya ShahA great place to begin taking charge of you arthritis pain relief and prevention planning is by making an appointment with your healthcare provider and finding out more about your condition and treatment options. Make sure to jot down questions ahead of time, and take them along in your journal or notebook, armed with a pencil to fill in his or her replies. Some questions to begin with may be centered around these:1. Do I have a form of arthritis? If not, what is wrong & what do I do next?2. If so, which type is it? And what can I expect short-term and long-term?3

  • Arthritis Pain Relief 101 - Coming of age equals coming of a variety of body pains. And do you know what most of our oldies would complain about regarding this issue? Arthritis. An estimate of over 50 million Americans suffer from osteoarthritis, rheumatoid arthritis and other conditions related conditions.The most common form of arthritis is osteoarthritis. It is the kind of arthritis that usually affects nearly three-quarters of those over 50. At the onset of arthritis, pain is not a part of the major system yet. Morning and after rest stiffness and crackling joints are usually the first few symptoms that confirm the diagnosis of the condition. Upon the d

    • Privacy Policy: We no not collect any information about users of this website.

    Disclaimer: Please consult a fully licensed and qualified medical professional about matters relating to arthritis. The articles featured on this site are for information purposes only and should not under any circumstance be relied on as professional advice.